Fisher & Paykel Healthcare (FSPKF) Stock Price, News & Analysis

Company Overview

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Key Stats

• Today's Range: $20.70 to $20.70
• 50-Day Range: $16.35 to $22.00
• 52-Week Range: $16.35 to $25.91
• Volume: N/A
• Average Volume: 1,175 shs
• Market Capitalization: N/A
• P/E Ratio: 122.03
• Dividend Yield: 0.32%
• Price Target: N/A
• Consensus Rating: N/A

Fisher & Paykel Healthcare Stock Analysis - MarketRank™

Fisher & Paykel Healthcare scored higher than 1% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Fisher & Paykel Healthcare.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Fisher & Paykel Healthcare is 122.03, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.52.

Price to Earnings Ratio vs. Sector

The P/E ratio of Fisher & Paykel Healthcare is 122.03, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.98.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Fisher & Paykel Healthcare has a short interest ratio ("days to cover") of 923.8, which indicates bearish sentiment.

Change versus previous month

Short interest in Fisher & Paykel Healthcare has recently decreased by 0.85%, indicating that investor sentiment is improving.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Fisher & Paykel Healthcare pays a meaningful dividend of 2.29%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Fisher & Paykel Healthcare does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Fisher & Paykel Healthcare is 38.45%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Fisher & Paykel Healthcare has a short interest ratio ("days to cover") of 923.8, which indicates bearish sentiment.

Change versus previous month

Short interest in Fisher & Paykel Healthcare has recently decreased by 0.85%, indicating that investor sentiment is improving.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Fisher & Paykel Healthcare this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Fisher & Paykel Healthcare insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 31.42% of the stock of Fisher & Paykel Healthcare is held by institutions.

FSPKF Stock Analysis - Frequently Asked Questions

How have FSPKF shares performed this year?

Fisher & Paykel Healthcare's stock was trading at $25.91 at the start of the year. Since then, FSPKF stock has decreased by 20.1% and is now trading at $20.70.
View the best growth stocks for 2025 here.

How do I buy shares of Fisher & Paykel Healthcare?

Shares of FSPKF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 5/25/2025
• Next Earnings (Estimated): 5/27/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:FSPKF
• CIK: N/A
• Web: www.fphcare.com
• Phone: (649) 574-0100
• Fax: N/A
• Employees: 6,391
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 122.03
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A